Proceedings of the International Consensus Conference on Cutaneous T-cell Lymphoma (CTCL) Treatment Recommendations : Boston, Massachusetts, Oct. 1 and 2, 1994 - 11/09/11
Doi : 10.1016/S0190-9622(97)80226-5
Marie-France Dernierre, MD, FRCPC, Francine M. Foss, MD, Howard K. Koh, MD, MPH ⁎
Skin Oncology Program and the Departments of Dermatology and Medicine, Boston, Massachusetts, USA
**Reprint requests: Howard K. Koh, MD, MPH, Professor of Dermatology, Medicine and Public Health, Boston University Medical Center, 720 Harrison Ave., D.O.B. 801A, Boston, MA 02118-2334.
Abstract |
At the International Consensus Conference for Cutaneous T-Cell Lymphoma (CTCL) Treatment Recommendations (held in Boston, Massachusetts, Oct. 1 and 2, 1994), international experts were asked to assess where consensus existed and to identify areas that required clinical research. We review the epidemiology, pathology, and immunology of CTCL, summarize the important areas in which consensus exists, and discuss newer targeted therapies.
Le texte complet de cet article est disponible en PDF.| * | Financial support of the conference was provided by educational grants from Hoffmann-La Roche, Schering Corporation, Seragen, and Therakos. |
© 1997
Publié par Elsevier Masson SAS. Tous droits réservés.
Vol 36 - N° 3
P. 460-466 - mars 1997 Retour au numéro
Article précédent
- Cutaneous manifestations of sports participation
- David B. Pharis, Craig Teller, John E. Wolf
- Undergraduate medical education in dermatology: Report from the AAD interdisciplinary education committee, subcommittee on undergraduate medical education
- Alfred Knable, Antoinette F. Hood, Thomas G. Pearson
Bienvenue sur EM-consulte, la référence des professionnels de santé.
L’accès au texte intégral de cet article nécessite un abonnement.
Déjà abonné à cette revue ?